[{"id":270,"run_id":19,"as_of":"2026-08-11","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":55.7,"technical":67.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":4000.0,"sizing_high":7000.0,"sizing_label":"Probe","close":277.8,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":13.7,"Sponsorship / positioning":5.5,"Catalyst alignment (insider)":2.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":null,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-11T03:29:59.217548+00:00"},{"id":1488,"run_id":29,"as_of":"2026-08-13","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":56.1,"technical":67.6,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":4000.0,"sizing_high":7000.0,"sizing_label":"Probe","close":284.37,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":14.0,"Sponsorship / positioning":5.6,"Catalyst alignment (insider)":2.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":null,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-13T00:18:50.531812+00:00"},{"id":2166,"run_id":44,"as_of":"2026-08-14","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":55.0,"technical":66.2,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":4000.0,"sizing_high":7000.0,"sizing_label":"Probe","close":280.05,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":5.5,"Catalyst alignment (insider)":2.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":null,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-14T02:10:25.224265+00:00"},{"id":3443,"run_id":58,"as_of":"2026-08-17","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":53.0,"technical":66.2,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (5 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":284.5,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":5.5,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997253560207888,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-17T19:19:32.921075+00:00"},{"id":4077,"run_id":65,"as_of":"2026-08-18","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":53.2,"technical":66.5,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (5 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":279.19,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":13.4,"Sponsorship / positioning":5.3,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997253560207888,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-18T23:32:56.598131+00:00"},{"id":4849,"run_id":146,"as_of":"2026-08-21","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":54.6,"technical":68.2,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":291.45,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":14.7,"Sponsorship / positioning":5.4,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997317966996858,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-21T12:50:47.832736+00:00"},{"id":5852,"run_id":262,"as_of":"2026-08-24","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":54.8,"technical":68.5,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":298.58,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":14.7,"Sponsorship / positioning":5.6,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997317966996858,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-24T22:18:32.103827+00:00"},{"id":6459,"run_id":268,"as_of":"2026-08-25","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":55.3,"technical":69.1,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":297.64,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":15.3,"Sponsorship / positioning":5.5,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997317966996858,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-25T20:43:40.461183+00:00"},{"id":7218,"run_id":310,"as_of":"2026-08-26","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":55.1,"technical":68.9,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). There is no offsetting insider purchase — this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":295.1,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":16.0,"Cross-asset confirmation":15.2,"Sponsorship / positioning":5.4,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997317966996858,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-26T21:05:17.706386+00:00"},{"id":7893,"run_id":391,"as_of":"2026-08-27","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":57.9,"technical":72.4,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). Other insiders bought (1 Officer), but the group remains net sellers; there is no CFO purchase to offset the selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":296.41,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":14.1,"Sponsorship / positioning":5.3,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997951691940475,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-27T20:58:37.306427+00:00"},{"id":8520,"run_id":412,"as_of":"2026-08-28","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":57.9,"technical":72.4,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). Other insiders bought (1 Officer), but the group remains net sellers; there is no CFO purchase to offset the selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":296.41,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":14.1,"Sponsorship / positioning":5.3,"Catalyst alignment (insider)":0.0},"total_cfo_value":0.0,"total_other_value":4364.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 Officer","npr":-0.9997951691940475,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-29T13:46:26.056206+00:00"},{"id":9231,"run_id":416,"as_of":"2026-08-31","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":56.8,"technical":71.0,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":288.24,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":13.5,"Sponsorship / positioning":4.8,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-09-01T06:06:09.907233+00:00"},{"id":9880,"run_id":419,"as_of":"2026-09-02","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":57.4,"technical":71.8,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":291.76,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":14.8,"Sponsorship / positioning":4.1,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-09-03T04:37:03.339000+00:00"},{"id":10502,"run_id":426,"as_of":"2026-09-04","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":64.5,"technical":80.6,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":293.35,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":15.1,"Sponsorship / positioning":10.9,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-05T07:11:17.284518+00:00"},{"id":11182,"run_id":431,"as_of":"2026-09-08","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":62.4,"technical":78.0,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":280.76,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":13.3,"Sponsorship / positioning":10.6,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-09-09T06:02:12.875570+00:00"},{"id":11766,"run_id":435,"as_of":"2026-09-09","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":62.3,"technical":77.9,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":278.35,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":13.3,"Sponsorship / positioning":10.5,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-09-10T07:14:31.451257+00:00"},{"id":12452,"run_id":439,"as_of":"2026-09-11","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":62.2,"technical":77.8,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":278.26,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":13.3,"Sponsorship / positioning":10.4,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-12T02:45:24.619644+00:00"},{"id":13045,"run_id":441,"as_of":"2026-09-14","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":62.9,"technical":78.6,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":273.11,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":14.1,"Sponsorship / positioning":10.3,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-15T03:28:57.380652+00:00"},{"id":13635,"run_id":443,"as_of":"2026-09-15","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":63.2,"technical":79.0,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":272.88,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":14.5,"Sponsorship / positioning":10.2,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-16T02:36:44.639998+00:00"},{"id":14235,"run_id":449,"as_of":"2026-09-16","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":64.1,"technical":80.1,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":273.41,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":15.4,"Sponsorship / positioning":10.2,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-17T09:11:29.927004+00:00"},{"id":14830,"run_id":454,"as_of":"2026-09-17","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":63.9,"technical":79.9,"stage":"Early Trend Expansion","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 0 buying). No insider purchase offsets the selling; this is one-way selling."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":281.67,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":20.0,"Cross-asset confirmation":15.2,"Sponsorship / positioning":10.2,"Catalyst alignment (insider)":0.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":-1.0,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-18T02:26:14.432907+00:00"},{"id":15563,"run_id":457,"as_of":"2026-10-15","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":55.3,"technical":65.4,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). The CFO purchase is contradicted by the rest of the insider group."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":306.24,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":19.8,"Volatility behaviour":12.5,"Cross-asset confirmation":20.0,"Sponsorship / positioning":0.0,"Catalyst alignment (insider)":3.0},"total_cfo_value":2974.0,"total_other_value":0.0,"n_cfo_buys":1.0,"n_other_buys":0.0,"has_cfo_buy":true,"roles_buying":"1 CFO","npr":-0.9998613906498066,"cluster_insiders":1.0,"days_since_buy":15.0,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-10-16T01:07:26.908361+00:00"},{"id":16163,"run_id":459,"as_of":"2026-10-16","ticker":"CRL","company":"Charles River Laboratories","source":"scan","conviction":54.3,"technical":64.1,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Insiders are net sellers — net purchase ratio -1.00 over the last 180 days (6 selling vs 1 buying). The CFO purchase is contradicted by the rest of the insider group."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":300.15,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":18.8,"Volatility behaviour":12.5,"Cross-asset confirmation":20.0,"Sponsorship / positioning":0.0,"Catalyst alignment (insider)":3.0},"total_cfo_value":2974.0,"total_other_value":0.0,"n_cfo_buys":1.0,"n_other_buys":0.0,"has_cfo_buy":true,"roles_buying":"1 CFO","npr":-0.9998613906498066,"cluster_insiders":1.0,"days_since_buy":16.0,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-10-17T01:36:17.814310+00:00"}]